MANGROVE PARTNERS IM LLC 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 12:38 pm Sale | 2023-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | MANGROVE PARTNERS IM LLC | 137,575 2.590% | -175,347 (-56.04%) | Filing |
| 2023-02-14 1:45 pm Purchase | 2022-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | MANGROVE PARTNERS IM LLC | 312,923 5.970% | 33,726 (+12.08%) | Filing |
| 2022-07-27 4:37 pm Purchase | 2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC | MANGROVE PARTNERS IM LLC | 279,197 5.370% | 12,500 (+4.69%) | Filing |
| 2022-05-23 5:39 pm Purchase | 2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC | MANGROVE PARTNERS IM LLC | 266,697 5.140% | 3,971 (+1.51%) | Filing |